JOHNSON & JOHNSON - CATALYST BIOSCIENCES INC ownership

CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 37 filers reported holding CATALYST BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
JOHNSON & JOHNSON ownership history of CATALYST BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$32,290
+37.2%
66,9510.0%0.01%
+71.4%
Q2 2023$23,540
+69.9%
66,9510.0%0.01%
+40.0%
Q1 2023$13,859
+39497.1%
66,9510.0%0.01%
-50.0%
Q4 2022$35
-99.9%
66,9510.0%0.01%0.0%
Q3 2022$34,000
-71.4%
66,9510.0%0.01%
-66.7%
Q2 2022$119,000
+170.5%
66,9510.0%0.03%
+275.0%
Q1 2022$44,000
-27.9%
66,9510.0%0.01%
+14.3%
Q4 2021$61,000
-77.8%
66,9510.0%0.01%
-70.8%
Q3 2021$275,00066,9510.02%
Other shareholders
CATALYST BIOSCIENCES INC shareholders Q4 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,076,376$13,321,0006.97%
22NW, LP 1,429,242$6,189,0001.66%
Ghost Tree Capital, LLC 1,000,000$4,330,0001.19%
ACUTA CAPITAL PARTNERS, LLC 685,000$2,966,0001.18%
Sio Capital Management, LLC 623,892$2,701,0000.67%
Parkman Healthcare Partners LLC 393,449$1,704,0000.37%
Nantahala Capital Management 2,531,360$10,961,0000.31%
AlphaCentric Advisors LLC 182,500$790,0000.22%
Ikarian Capital, LLC 581,200$2,518,0000.20%
Tibra Equities Europe Ltd 79,200$343,0000.11%
View complete list of CATALYST BIOSCIENCES INC shareholders